お知らせ • Apr 25
Croda International plc Approves Final Dividend Croda International Plc at its AGM held on April 22, 2026 approved a final dividend of 63.0 pence per ordinary share. お知らせ • Feb 25
Croda International Plc, Annual General Meeting, Apr 22, 2026 Croda International Plc, Annual General Meeting, Apr 22, 2026. お知らせ • Feb 24
Croda International plc Recommends Final Dividend for the Financial Year Ended December 31, 2025, Payable on 27 May 2026 Croda International Plc announced that the Directors are recommending a final dividend of 63 pence per share amounting to a total of £87.9 million in respect of the financial year ended 31 December 2025. Subject to shareholder approval, the dividend will be paid on 27 May 2026 to shareholders registered on 10 April 2026. The total proposed dividend for the year ended 31 December 2025 will be 111 pence per share amounting to £154.9 million. お知らせ • Jan 09
Croda International Plc Announces Appointment of Jill Anderson as Non-Executive Director and Member of the Audit, Nomination and Remuneration Committees, Effective January 12, 2026 Croda International Plc announced the appointment of Jill Anderson as a Non-Executive Director. Jill will join the Board on January 12, 2026 and become a member of the Audit, Nomination and Remuneration Committees. Jill brings more than 30 years' experience in international leadership positions in the healthcare industry, including executive responsibility in finance, commercial research and supply chain functions. Most recently, Jill was Chief Financial Officer of GSK's R&D division until she retired in 2024. Jill is currently a Non-Executive Director and Audit Committee Chair at Spire Healthcare Group plc. お知らせ • Oct 17
Croda International plc Provides Earnings Guidance for the Fourth Quarter and Full Year of Fiscal Year 2025 Croda International Plc provided earnings guidance for the fourth quarter and full year of fiscal year 2025. For the quarter, the company absolute sales in quarter 4 are likely to be seasonally lower than in the first 3 quarters as customers typically manage their working capital into the year-end. Despite this, the combination of good sales growth year-to-date and anticipated cost savings means that the company continue to expect GBP 265 million to GBP 295 million of group adjusted profit before tax at constant currency.
For the full year, the company reiterated full year guidance. お知らせ • Jul 31
Croda International plc Announces an Interim Dividend in Respect of 2025, Payable on 7 October 2025 Croda International Plc announced an interim dividend in respect of 2025 of 48.0 pence per share, amounting to a total dividend of £67.0 million, was declared by the Directors at their meeting on 25 July 2025. This interim report does not reflect the 2025 interim dividend payable. The dividend will be paid on 7 October 2025 to shareholders registered on 29 August 2025. お知らせ • Mar 04
Croda International Plc Announces Retirement of Julie Kim from the Board, Effective July 26, 2025 Croda International Plc announced that Julie Kim will retire from the Board on 26 July 2025, having served four years as a non-executive director, in order to focus on her executive commitments. Julie has recently been named as the next CEO of Takeda Pharmaceutical. お知らせ • Feb 26
Croda International Plc, Annual General Meeting, Apr 23, 2025 Croda International Plc, Annual General Meeting, Apr 23, 2025. お知らせ • Feb 25
Croda International plc Recommends Final Dividend for the Financial Year Ended December 31, 2024, Payable on May 28, 2025 The Directors of Croda International Plc are recommending a final dividend of 63 pence per share amounting to a total of £87.9 million in respect of the financial year ended 31 December 2024. Subject to shareholder approval, the dividend will be paid on 28 May 2025 to shareholders registered on 11 April 2025. The total proposed dividend for the year ended 31 December 2024 will be 110 pence per share amounting to £153.5 million. The Board is proposing to increase the full year dividend to 110 pence (2023: 109 pence), despite temporarily taking company above its stated percentage of adjusted profit after tax, reflecting its confidence in delivery of future earnings growth. お知らせ • Nov 19
Croda International plc Announces Directorate Change Croda International Plc announced that John Ramsay, having served as a non-executive director and Chair of Audit Committee for over 5 years, will retire from the Board on 1 March 2025 and not seek re-election at the 2025 AGM (due to increased business and personal commitments). In preparation for John's retirement next year, Ian Bull will take over as Chair of the Audit Committee with effect from 1 December 2024 and so lead the Committee over Croda's 2024 year-end. Ian has been a member of the Audit Committee since his appointment to the Board on 24 June 2024. Ian is currently the Audit Committee Chair of Dunelm Group plc, Senior Independent Director at Domino's Pizza Group plc and Fellow of the Chartered Institute of Management Accountants. John will remain a member of the Audit Committee, as well as the Nomination and Remuneration Committees until his retirement from the Board. お知らせ • Jun 27
Croda International Plc Appoints Ian Bull as Non-Executive Director and Member of the Audit, Nomination and Remuneration Committees The Board of Croda International Plc announced the appointment of Ian Bull as a Non-Executive Director with effect from 25 June 2024. Ian has extensive experience with listed companies across a wide range of industries, both domestic and international, both as an Executive Director as well as Senior Independent Director and Audit Committee Chair. He was previously Group Finance Director of Greene King plc, Chief Financial Officer at Ladbrokes plc, and was most recently Chief Financial Officer of Parkdean Resorts Group. Ian was formerly a non-executive Director of Paypoint Ltd, Chair of Lookers plc and Senior Independent Director and Audit Committee Chair of St. Modwen Properties plc. Ian is currently a Non-Executive Director and Audit Committee Chair of Dunelm Group plc and Senior Independent Director of Domino's Pizza Group Plc. He is a Fellow of the Chartered Institute of Management Accountants. On joining the Board, Ian will be appointed to the Audit, Nomination and Remuneration Committees. お知らせ • Apr 27
Croda International Plc Declares Final Dividend Croda International Plc at its Annual General Meeting held on 24 April 2024 declared a final dividend of 62.0 pence per ordinary share. お知らせ • Feb 29
Croda International plc Recommends Final Dividend in Respect of the Financial Year Ended 31 December 2023, Payable on 29 May 2024 The Directors of Croda International Plc are recommending a final dividend of 62.0 pence per share amounting to a total of £86.5m in respect of the financial year ended 31 December 2023. Subject to shareholder approval, the dividend will be paid on 29 May 2024 to shareholders registered on 19 April 2024. The total proposed dividend for the year ended 31 December 2023 will be 109.0pper share amounting to £152.1m. お知らせ • Dec 20
Croda International plc Announces Louisa Burdett, Chief Financial Officer, Intends to Leave in June 2024 Croda International Plc announced that Louisa Burdett, Chief Financial Officer, intends to leave the Company in June 2024 to become Chief Financial Officer at Spirax-Sarco Engineering plc. お知らせ • Dec 19
Croda International plc Announces Resignation of Louisa Burdett from Board Croda International Plc announced that Louisa Burdett, Non-Executive Director, will leave the board in June 2024. お知らせ • Jul 06
Croda International Plc (LSE:CRDA) completed the acquisition of Solus Biotech Co., Ltd. from Solus Advanced Materials Co., Ltd. (KOSE:A336370). Croda International Plc (LSE:CRDA) agreed to acquire Solus Biotech Co., Ltd. from Solus Advanced Materials Co., Ltd. (KOSE:A336370) for KRW 350 billion on February 3, 2023. The acquisition is subject to regulatory approval. Lazard & Co., Limited acted as financial advisor to Croda International Plc (LSE:CRDA).Croda International Plc (LSE:CRDA) completed the acquisition of Solus Biotech Co., Ltd. from Solus Advanced Materials Co., Ltd. (KOSE:A336370) on July 4, 2023. The acquisition comes following receipt of unconditional approval from the South Korean regulatory authorities. お知らせ • Feb 07
Croda International Plc (LSE:CRDA) agreed to acquire Solus Biotech Co., Ltd. from Solus Advanced Materials Co., Ltd. (KOSE:A336370) for KRW350 billion. Croda International Plc (LSE:CRDA) agreed to acquire Solus Biotech Co., Ltd. from Solus Advanced Materials Co., Ltd. (KOSE:A336370) for KRW350 billion on February 6, 2023. The acquisition is subject to regulatory approval. お知らせ • Mar 04
Croda International Plc to Report Fiscal Year 2022 Results on Mar 07, 2023 Croda International Plc announced that they will report fiscal year 2022 results on Mar 07, 2023